CIK 0000771856
- Non-accelerated filer
- Smaller reporting company
CHAMPIONS ONCOLOGY, INC.
Sign in to watch- Ticker
- CSBR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Apr 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521401755
- Phone
- +1 410-369-0365
- Business address
- 855 N. WOLFE STREET, SUITE 619, BALTIMORE, MD, 21205
- Former names
- CHAMPIONS BIOTECHNOLOGY, INC., CHAMPIONS SPORTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-05 | ACKERMAN JOEL Director | Grant or award · Option to purchase Common Stock | +31,216 | $4.76 | $149K | 31,216 |
| 2026-10-15 | ACKERMAN JOEL Director | Exercise or conversion | +69,794 | $1.60 | $112K | 1,126,333 |
| 2026-10-15 | ACKERMAN JOEL Director | Exercise or conversion · Option to purchase Common Stock | −69,794 | $1.60 | $112K | 0 |
| 2025-11-05 | ACKERMAN JOEL Director | Grant or award · Option to purchase Common Stock | +21,216 | $6.80 | $144K | 21,216 |
| 2025-10-30 | ACKERMAN JOEL Director | Exercise or conversion | +94,405 | $2.10 | $198K | 1,056,539 |
| 2025-10-30 | ACKERMAN JOEL Director | Exercise or conversion · Option to purchase Common Stock | −94,405 | $2.10 | $198K | 0 |
| 2024-11-12 | ACKERMAN JOEL Director | Grant or award · Option to purchase Common Stock | +43,190 | $4.64 | $200K | 43,190 |
| 2024-10-31 | ACKERMAN JOEL Director | Exercise or conversion | +88,470 | $2.10 | $186K | 945,467 |
| 2024-10-31 | ACKERMAN JOEL Director | Exercise or conversion | +16,667 | $5.43 | $91K | 962,134 |
| 2024-10-31 | ACKERMAN JOEL Director | Exercise or conversion · Option to purchase Common Stock | −88,470 | $2.10 | $186K | 0 |
| 2024-10-31 | ACKERMAN JOEL Director | Exercise or conversion · Option to purchase Common Stock | −16,667 | $5.43 | $91K | 0 |
| 2023-11-03 | ACKERMAN JOEL Director | Grant or award · Option to purchase Common Stock | +35,750 | $5.51 | $197K | 35,750 |
| 2023-10-17 | ACKERMAN JOEL Director | Exercise or conversion | +114,552 | $2.10 | $241K | 856,997 |
| 2023-10-17 | ACKERMAN JOEL Director | Exercise or conversion · Option to purchase Common Stock | −100,000 | $2.10 | $210K | 0 |
| 2023-10-17 | ACKERMAN JOEL Director | Exercise or conversion · Option to purchase Common Stock | −14,552 | $2.10 | $31K | 0 |
| 2022-11-01 | ACKERMAN JOEL Director | Grant or award · Option to purchase Common Stock | +26,500 | $7.00 | $186K | 26,500 |
| 2022-10-19 | ACKERMAN JOEL Director | Exercise or conversion | +16,667 | $3.21 | $54K | 1,460,595 |
| 2022-10-19 | ACKERMAN JOEL Director | Exercise or conversion · Option to purchase Common Stock | +16,667 | 0 | ||
| 2021-11-05 | ACKERMAN JOEL Director | Grant or award · Option to purchase Common Stock | +18,564 | $10.10 | $187K | 18,564 |
| 2020-12-08 | ACKERMAN JOEL Director | Grant or award · Option to purchase Common Stock | +16,667 | $11.96 | $199K | 16,667 |
Page 1 of 5 · 94 trades